Benzinga · Sep 30, 2026
B. Riley Securities Maintains Buy on IperionX, Lowers Price Target to $34
B. Riley Securities analyst Lucas Pipes maintains IperionX (NASDAQ:IPX) with a Buy and lowers the price target from $52 to $34.
NASDAQ · IPX
Basic Materials · Industrial Materials
$15.28
Down-$0.55 (-3.47%)
Updated Oct 9, 2026, 7:01 AM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · IPX
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 8, 2026
IPX closed at $15.28 after 21 trading sessions, down 21.32% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 8, 2026 | $15.54 | $15.64 | $15.05 | $15.28 | 247.82K |
| Oct 7, 2026 | $16.42 | $16.42 | $15.64 | $15.83 | 227.79K |
| Oct 6, 2026 | $16.88 | $17.37 | $16.84 | $17.01 | 165.26K |
| Oct 5, 2026 | $16.81 | $17.03 | $16.4506 | $16.61 | 151.61K |
| Oct 2, 2026 | $16.52 | $17.54 | $16.52 | $16.97 | 264.07K |
| Oct 1, 2026 | $16.45 | $16.45 | $15.34 | $15.82 | 389.73K |
| Sep 30, 2026 | $17.80 | $18.18 | $16.67 | $16.82 | 609.46K |
| Sep 29, 2026 | $18.75 | $18.93 | $18.17 | $18.30 | 258.33K |
| Sep 28, 2026 | $18.88 | $19.21 | $18.56 | $18.75 | 196.89K |
| Sep 25, 2026 | $19.62 | $19.755 | $19.00 | $19.61 | 160.36K |
| Sep 24, 2026 | $19.54 | $20.05 | $19.2051 | $19.62 | 145.36K |
| Sep 23, 2026 | $20.38 | $20.39 | $19.44 | $19.77 | 315.51K |
| Sep 22, 2026 | $21.47 | $21.77 | $20.99 | $21.47 | 225.36K |
| Sep 21, 2026 | $21.22 | $21.82 | $20.825 | $21.05 | 261.2K |
| Sep 18, 2026 | $20.97 | $21.24 | $20.33 | $20.85 | 594.8K |
| Sep 17, 2026 | $19.54 | $21.18 | $19.36 | $20.97 | 839.24K |
| Sep 16, 2026 | $18.68 | $19.84 | $18.26 | $19.23 | 1.07M |
| Sep 15, 2026 | $18.00 | $18.2299 | $17.64 | $18.155 | 286.44K |
| Sep 14, 2026 | $17.98 | $18.53 | $17.40 | $18.13 | 476.49K |
| Sep 11, 2026 | $19.44 | $19.49 | $18.61 | $18.67 | 238.31K |
| Sep 10, 2026 | $20.35 | $20.68 | $19.26 | $19.42 | 304.73K |
The latest Smart Investors Daily articles mentioning IPX.
Company
Market Activity
Research & News
IPX research
Company profile and research snapshot.
IperionX Ltd produces titanium critical minerals, titanium powders, and titanium end products for various industries. The company's breakthrough titanium technologies have demonstrated the potential to produce titanium products that are sustainable, recyclable, and have low carbon intensity. IperionX is producing titanium metal powders from titanium scrap at its operational pilot facility in Utah, It also owns a titan critical minerals project, the Titan Project, covering over 11,000 acres of critical minerals that include titanium, rare earth elements, silica sand, and zircon in Tennessee, United States.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 30, 2026 | BELL POTTER SECURITIES | Buy | — |
| Jun 25, 2026 | CANACCORD GENUITY | Buy | — |
| Jun 24, 2026 | CANACCORD GENUITY | Buy | — |
| Jun 4, 2026 | BELL POTTER SECURITIES | Buy | — |
| Jun 3, 2026 | BELL POTTER SECURITIES | Buy | — |
No generated briefing is available yet.
Benzinga · Sep 30, 2026
B. Riley Securities analyst Lucas Pipes maintains IperionX (NASDAQ:IPX) with a Buy and lowers the price target from $52 to $34.
Yahoo · Sep 16, 2026
Advancing titanium beyond batch production: GenX™ has validated continuous HAMR™ processing, advancing beyond the batch model used in conventional Kroll titanium production. Major operating gains support the potential for lower unit costs, higher titanium throughput, and a modular capital-efficient expansion pathwayVerified oxygen results: All valid product samples met the relevant oxygen benchmark: ASTM Grade 5 for angular powder and the more stringent Grade 23 specification for spherical titan
Benzinga · Sep 2, 2026
Jefferies analyst Laurence Alexander initiates coverage on IperionX (NASDAQ:IPX) with a Buy rating and announces Price Target of $26.
Yahoo · Aug 31, 2026
SOUTH BOSTON, Va., Aug. 31, 2026 (GLOBE NEWSWIRE) -- IperionX Limited (IperionX) (NASDAQ: IPX, ASX: IPX) IperionX Limited announces that the U.S. Army has awarded Task Order 2 under the Small Business Innovation Research (SBIR) Phase III Indefinite Delivery, Indefinite Quantity (IDIQ) contract for Low-Cost, Domestic Titanium for Defense Applications. IperionX’s SBIR Phase III IDIQ contract enables qualifying U.S. Government agencies to place project-specific orders collectively capped at US$99 m
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning IPX.
No results
No recent SID articles mention IPX.